Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
Cystadenocarcinoma, Serous
×
Gynecologic
×
Clear all
Filters
3
NCT04159155
2025-08-12
CAN-STAMP
University Health Network, Toronto
Phase 2/3
Terminated
11 enrolled
NCT04055038
2019-08-13
EPITOC
Blokhin's Russian Cancer Research Center
Phase 2/3
Unknown
164 enrolled